Bulletin of Semashko National Research Institute of Public HealthBulletin of Semashko National Research Institute of Public Health2415-84102415-8429FSSBI «N.A. Semashko National Research Institute of Public Health»281410.69541/NRIPH.2024.04.018Научная статьяDevelopment and expert evaluation of measures to improve the organization of medical care for patients with oncological diseases in regions of the Russian FederationKhailovaZhanna V.1977zhanna@mail.ruhttps://orcid.org/0000-0003-3258-0954OmelyanovskyVitaly V.office@rosmedex.ruhttps://orcid.org/0000-0003-1581-0703MikhailovIlya A.mikhailov@rosmedex.ruhttps://orcid.org/0000-0001-8020-369XKomarovYuri I.center.petrova@niioncologii.ruhttps://orcid.org/0000-0003-3256-0451SlabikovaAlexandra A.slabikova@rosmedex.ruhttps://orcid.org/0009-0001-7817-5180IvanovSergey A.mnioi@mail.ruhttps://orcid.org/0000-0001-7689-6032KaprinAndrey D.noreply@nriph.ruhttps://orcid.org/0000-0001-8784-8415National Medical Research Radiological Centre of the Ministry of Health of the Russian FederationRussian Medical Academy for Continuous Professional EducationCenter of Expertise and Quality Control of Healthcare of the Ministry of Health of the Russian FederationN. A. Semashko National Research Institute of Public HealthFinancial Research Institute of the Ministry of Finance of the Russian FederationNational Medical Research Centre of Oncology named after N.N.Petrov of the Ministry of Health of the Russian FederationITMO UniversityPeoples' Friendship University of Russia named after Patrice Lumumba27112024411612607052025Copyright © 2025,2025<p>The objective of the study was to develop an index of innovative readiness of the environment for the implementation of innovative technologies at the level of a healthcare organization. The following materials were used: legislation in the field of healthcare, including compulsory medical insurance: federal laws of the Russian Federation, decrees of the Government of the Russian Federation, orders of the Ministry of Health of Russia, and other methodological materials. Foreign and domestic scientific publications devoted to the implementation of innovative medical technologies in healthcare organizations were also used. Factors and parameters that determine the readiness of the environment of a healthcare organization for the implementation of certain medical technologies were extracted from regulatory legal acts and scientific publications in a structured form. Criteria for a comprehensive analysis of the possibility of implementing an innovative medical technology in a healthcare organization, combined into 8 main blocks, on key aspects of assessing the regional healthcare system in terms of implementing innovations: sufficient qualifications and motivation (interest) of personnel; readiness and interest of the management of the healthcare organization and the founder in implementing the innovative method; sufficient patient population for using the innovative method; availability of practical experience in using analogs of the innovative method in a healthcare organization; availability of the necessary equipment and/or drugs; availability of the necessary buildings and premises; preliminary assessment of the clinical and economic efficiency of implementing an innovative method in a medical organization; sufficiency of tariffs and volumes of medical care for the innovative method and its analogue (comparison method) in a medical organization. The environment of a medical organization is recognized as ready for implementing an innovative medical technology if the total number of points on the checklist is 8 or more points (there must be a yes answer to at least one item from each section of the checklist, +1 additional point for one more yes answer in any of the sections).</p>innovative technologieshealthcare managementmedical organizationimplementation of innovative medical technologiesclinical testingуправление здравоохранениемонкологические заболеваниянациональные проектыфедеральные проектыоказание медицинской помощиорганизация оказания медицинской помощи[Malignant neoplasms in Russia in 2022 (incidence and mortality). P.A.Herzen Moscow Oncology Research Institute − branch of the Federal State Budgetary Institution “NMITs of Radiology” of the Ministry of Health of the Russian Federation; 2023 (in Russian).][Ushkalova E.A., Zyryanov S.K., Gopienko I.A. Economic challenges of oncological diseases’ pharmacotherapy. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. [FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya]. 2020;13(1):64—70 (in Russian). DOI: 10.17749/2070—4909.2020.13.1.64—70][Stylidi I.S., Gevorkyan T.G., Shpak A.G. Improvement of indicators of federal project “Fight against oncological diseases”. Bulletin of Roszdravnadzor. [Vestnik Roszdravnadzora]. 2021;(1):46—53 (in Russian).][Shelyakin V.A., Linnik S.А., Tretyakov D.A., Khudyaev A.S., Shvachko S.A. Planning medical care for patients with cancer in the constituent entities of the Russian Federation. Health care manager. [Menedzher zdravookhraneniya]. 2023;(1):60—69 (in Russian). DOI: 10.21045/1811-0185-2023-1-60-69][Linnik S.A. Analysis of the provision of medicines to patients with malignant neoplasms in the subjects of the Russian Federation. Public health and healthcare. [Obshchestvennoe zdorov'e i zdravookhranenie]. 2022;75(3):28—32 (in Russian).][Linnik S.A., Alexandrova O.Yu. Analysis of drug supply for patients with malignant neoplasms at the inpatient stage of treatment. Health care manager. [Menedzher zdravookhraneniya]. 2023;(2):18—26 (in Russian). DOI: 10.21045/1811-0185-2023-2-18-26][Shelyakin V.A., Linnik S.A., Tretyakov D.A., Tumenko E.E., Khudyaev A.S. Analyses of the effectiveness of molecular genetic testing of patients with cancer on the examples of some subjects of the Russian Federation. Bulletin of Semashko National Research Institute of Public Health. [Byulleten' Natsional'nogo nauchno-issledovatel'skogo instituta obshchestvennogo zdorov'ya imeni N.A.Semashko]. 2022;(4):30—37 (in Russian). DOI: 10.25742/NRIPH.2022.04.006][Andreev D.A., Zavyalov A.A., Kashurnikov A.Y., Dobrodeev A.Y. Essential criteria for assessing the quality of cancer care: international experience. Russian Medical Journal. [Rossiyskiy meditsinskiy zhurnal]. 2020;26(6):421—430 (in Russian). DOI: 10.17816/0869-2106-2020-26-6-421-430][Gorkavenko FV, Shchurov DG, Omelyanovskiy VV. Multiple linear regression analysis of cancer treatment effectiveness at the level of constituent entities in the Russian Federation. Medical Technologies. Assessment and Choice. [Meditsinskie tekhnologii. Otsenka i vybor]. 2023;(1):9-26 (in Russian). DOI: 10.17116/medtech2023450119][Pustovalov D.N., Gorkavenko F.V., Tyurin I.E., Yablonskiy P.K., Shelekhov P.V., Dombrovskiy V.S., Minakova E.I., Morozov D.Yu., Semakova E.V., Kravtsov A.A., Prokhorovich E.A., Omelyanovskiy V.V. Cost-effectiveness analysis of low-dose computed tomography for lung cancer screening. Medical Technologies. Assessment and Choice. [Meditsinskie tekhnologii. Otsenka i vybor]. 2024;(1):60-73 (in Russian). DOI: 10.17116/medtech20244601160][Petkau V.V., Karimova A.A., Efremov S.A., Gruzdeva E.A. The influence of accessibility of anticancer drug therapy on the target indicators of the oncological service. Medical Council. [Meditsinskiy sovet]. 2021;(4S):80—86 (in Russian). DOI: 10.21518/2079-701X-2021-4S-80-86][Lomakov S.Yu. Professional view of doctors on improving the organization of radiation research for cancer patients. Research and Practical Medicine Journal. [Issledovaniya i praktika v meditsine]. 2020;7(3):127—135 (in Russian). DOI: 10.17709/2409-2231-2020-7-3-13]